Kashfi K - Search Results

1

NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.

Chattopadhyay M, Goswami S, Rodes DB, Kodela R, Velazquez CA, Boring D, Crowell JA, Kashfi K. Chattopadhyay M, et al. Among authors: kashfi k. Cancer Lett. 2010 Dec 8;298(2):204-11. doi: 10.1016/j.canlet.2010.07.006. Epub 2010 Jul 31. Cancer Lett. 2010. PMID: 20674154

2

The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines.

Merritt G, Aliprandis ET, Prada F, Rigas B, Kashfi K. Merritt G, et al. Among authors: kashfi k. Cancer Lett. 2001 Mar 10;164(1):15-23. doi: 10.1016/s0304-3835(00)00714-x. Cancer Lett. 2001. PMID: 11166911

3

Colon cancer prevention with NO-releasing NSAIDs.

Kaza CS, Kashfi K, Rigas B. Kaza CS, et al. Among authors: kashfi k. Prostaglandins Other Lipid Mediat. 2002 Feb;67(2):107-20. doi: 10.1016/s0090-6980(02)00003-5. Prostaglandins Other Lipid Mediat. 2002. PMID: 11936617 Review.

4

Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.

Nath N, Kashfi K, Chen J, Rigas B. Nath N, et al. Among authors: kashfi k. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12584-9. doi: 10.1073/pnas.2134840100. Epub 2003 Oct 17. Proc Natl Acad Sci U S A. 2003. PMID: 14566053 Free PMC article.

5

Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.

Williams JL, Nath N, Chen J, Hundley TR, Gao J, Kopelovich L, Kashfi K, Rigas B. Williams JL, et al. Among authors: kashfi k. Cancer Res. 2003 Nov 15;63(22):7613-8. Cancer Res. 2003. PMID: 14633677

6

NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression.

Nath N, Labaze G, Rigas B, Kashfi K. Nath N, et al. Among authors: kashfi k. Biochem Biophys Res Commun. 2005 Jan 7;326(1):93-9. doi: 10.1016/j.bbrc.2004.11.009. Biochem Biophys Res Commun. 2005. PMID: 15567157

7

Molecular targets of nitric-oxide-donating aspirin in cancer.

Kashfi K, Rigas B. Kashfi K, et al. Biochem Soc Trans. 2005 Aug;33(Pt 4):701-4. doi: 10.1042/BST0330701. Biochem Soc Trans. 2005. PMID: 16042578 Review.

8

Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.

Ouyang N, Williams JL, Tsioulias GJ, Gao J, Iatropoulos MJ, Kopelovich L, Kashfi K, Rigas B. Ouyang N, et al. Among authors: kashfi k. Cancer Res. 2006 Apr 15;66(8):4503-11. doi: 10.1158/0008-5472.CAN-05-3118. Cancer Res. 2006. PMID: 16618778

9

The mechanism of action of nitric oxide-donating aspirin.

Kashfi K, Rigas B. Kashfi K, et al. Biochem Biophys Res Commun. 2007 Jul 13;358(4):1096-101. doi: 10.1016/j.bbrc.2007.05.038. Epub 2007 May 15. Biochem Biophys Res Commun. 2007. PMID: 17512900

10

Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.

Nath N, Vassell R, Chattopadhyay M, Kogan M, Kashfi K. Nath N, et al. Among authors: kashfi k. Biochem Pharmacol. 2009 Nov 15;78(10):1298-304. doi: 10.1016/j.bcp.2009.06.104. Epub 2009 Jul 2. Biochem Pharmacol. 2009. PMID: 19576865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters